Yoko Shimada

Identification of Genes Upregulated in <i>ALK</i> -Positive and <i>EGFR/KRAS/ALK</i> -Negative Lung Adenocarcinomas

Hirokazu Okayama, Takashi Kohno, Yuko Ishii et al. · Cancer Research · 2011 · 865 citations · Full text

KIF5B-RET fusions in lung adenocarcinoma

Takashi Kohno, Hitoshi Ichikawa, Yasushi Totoki et al. · Nature Medicine · 2012 · 827 citations · Full text

Tumor Biology, Lung Adenocarcinoma, Tumor Suppressor +5

CS-514, a competitive inhibitor of 3-hydroxy-3-methylglutaryl coenzyme A reductase: tissue-selective inhibition of sterol synthesis and hypolipidemic effect on various animal species

Yoshio Tsujita, Masao Kuroda, Yoko Shimada et al. · Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism · 1986 · 374 citations

Oxysterol, Biochemistry, Medicine +9

A Synthetic Lethality–Based Strategy to Treat Cancers Harboring a Genetic Deficiency in the Chromatin Remodeling Factor BRG1

Takahiro Oike, Hideaki Ogiwara, Yuichi Tominaga et al. · Cancer Research · 2013 · 292 citations · Full text

Fgfr1 Gene Amplifications, Treat Cancers, Tumor Biology +19

Druggable Oncogene Fusions in Invasive Mucinous Lung Adenocarcinoma

Takashi Nakaoku, Koji Tsuta, Hitoshi Ichikawa et al. · Clinical Cancer Research · 2014 · 215 citations · Full text